Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

In­spec­tions

The Paul-Ehrlich-Institut is responsible for the performance of onsite inspections at e.g. pharmaceutical companies, investigator and sponsors sites, laboratories and service providers.

The PEI conducts worldwide inspections

  • to verify compliance with Good Clinical Practices (GCP) in connection with national clinical trial authorizations and national or European marketing authorizations (GCP-inspections)
  • in the scope of the European Plasma Master File Certification Procedure (PMF-inspections)
  • of pharmacovigilance systems (for human and veterinary medicinal products, haemovigilance and the vigilance of tissues and cells) (PhV-inspections)
  • within the national marketing authorization procedure in order to verify the data submitted.

In addition, experts of the PEI accompany inspections of the competent authorities of the federal states for the issuance of authorizations and certificates.

For all types of inspections, the employees of the PEI collaborate closely with those of the competent authorities of the federal states.

Contact

Section Inspections of Biomedicines
Email: inspektionen@pei.de

Updated: 24.01.2020